Oral corticosteroid-sparing effects of mepolizumab in severe eosinophilic asthma: evidence from randomized controlled trials and real-world studies

Oral corticosteroids (OCS) have long been a mainstay of treatment for asthma exacerbations and chronic severe asthma. However, it is increasingly recognized that both long-term and short-term OCS use are directly associated with a wide range of serious adverse effects, and as such OCS-sparing treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Casale, Thomas B., Burnette, Autumn, Bourdin, Arnaud, Howarth, Peter, Hahn, Beth, Stach-Klysh, Alexandra, Khurana, Sandhya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386863/
https://www.ncbi.nlm.nih.gov/pubmed/35972211
http://dx.doi.org/10.1177/17534666221107313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386863/
https://www.ncbi.nlm.nih.gov/pubmed/35972211
http://dx.doi.org/10.1177/17534666221107313

Ejemplares similares